It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client requirements that will shape 2025 and beyond. Subodh Deshmukh, CEO of Aragen Bioscience discusses.
It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client requirements that will shape 2025 and beyond. Subodh Deshmukh, CEO of Aragen Bioscience discusses.
Valentin Valkov Shutterstock
The week's biggest stories from this industry, direct to your inbox.
